Publications by authors named "Douglas Jacoby"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

133,619

Total Likes

2,766

Extended Reach

994,043

Social Features

131
R
Real-world experience of inclisiran prescription at the University of Pennsylvania Health Systems.
Nicole M Wei, Robert F Tobin, Douglas S Jacoby, Archna Bajaj

J Clin Lipidol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Technology-Assisted Web Application for Consumer Access to a Nonprescription Statin Medication.
Steven E Nissen, Howard G Hutchinson, Kathy Wolski, Karol Watson, Seth S Martin, Douglas Jacoby

J Am Coll Cardiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Lipid Screening During First Trimester of Pregnancy to Identify Women at Risk of Severe Dyslipidemia.
Sohil Golwala, Cara D Dolin, Richard Nemiroff, Daniel Soffer, Srinivas Denduluri, Douglas Jacoby

J Am Heart Assoc· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Acute Coronary Syndrome Disparities in Guideline-Directed Lipid Therapy and Insufficient Achievement of Optimal Low-Density Lipoprotein.
Maxwell Ambrosino, Sydney Emerson, Lauren Catalano, Erik Hossain, Howard M Julien, Douglas S Jacoby

Am J Cardiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019.
Julio A Chirinos, Patricio Lopez-Jaramillo, Evangelos J Giamarellos-Bourboulis, Gonzalo H Dávila-Del-Carpio, Abdul Rahman Bizri, Douglas Jacoby

Nat Metab· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preface.
Douglas S Jacoby

Med Clin North Am· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis.
Emily Keyes, Madison Grinnell, Douglas Jacoby, Thomas Vazquez, DeAnna Diaz

Int J Womens Dermatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study.
Samip Sheth, Paul Lee, Archna Bajaj, Marina Cuchel, Jihane Hajj, Douglas Jacoby

Circ Cardiovasc Qual Outcomes· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Subclinical Atherosclerosis Imaging to Guide Preventive Cardiology Management.
Meshal Soni, Maxwell Ambrosino, Douglas S Jacoby

Curr Cardiol Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging.
Senthil Selvaraj, Muhammad Shoaib Khan, Mahesh K Vidula, Philip C Wiener, Alejandro E de Feria, Douglas Jacoby

Open Heart· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study.
Juan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, Maureen G Maguire, Ebenezer Daniel, Douglas Jacoby

Br J Ophthalmol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Passive Choice and Active Choice Interventions in the Electronic Health Record to Cardiologists on Statin Prescribing: A Cluster Randomized Clinical Trial.
Srinath Adusumalli, Julie E Westover, Douglas S Jacoby, Dylan S Small, Christine VanZandbergen

JAMA Cardiol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "Centrality of Sepsis": A Review on Incidence, Mortality, and Cost of Care.
Jihane Hajj, Natalie Blaine, Jola Salavaci, Douglas Jacoby

Healthcare (Basel)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinical Guide to Combination Lipid-Lowering Therapy.
Cori Russell, Samip Sheth, Douglas Jacoby

Curr Atheroscler Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving cardiovascular outcomes by intensifying low density lipoprotein lowering therapy in high-risk patients.
Douglas S Jacoby, Daniel J Rader

Eur Heart J· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated cholesterol guidelines and intensity of statin therapy.
Vincent Nguyen, Emil M deGoma, Erik Hossain, Douglas S Jacoby

J Clin Lipidol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carotid intima-media thickness measurement promises to improve cardiovascular risk evaluation in head and neck cancer patients.
Douglas Jacoby, Jihane Hajj, Ali Javaheri, Emil deGoma, Alexander Lin

Clin Cardiol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced lipid testing: when, why, and in whom?
Karol E Watson, Eric H Stocker, Douglas S Jacoby, Peter A McCullough

Rev Cardiovasc Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in absolute risk of cardiovascular events using risk-refinement tests: a systematic analysis of four cardiovascular risk equations.
Emil M deGoma, Richard L Dunbar, Douglas Jacoby, Benjamin French

Atherosclerosis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agents that bind annexin A2 suppress ocular neovascularization.
Raquel Lima e Silva, Jikui Shen, Yuan Yuan Gong, Christopher P Seidel, Sean F Hackett, Douglas B Jacoby

J Cell Physiol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.
Kamala Kesavan, Judson Ratliff, Eric W Johnson, William Dahlberg, John M Asara, Douglas B Jacoby

J Biol Chem· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide.
Douglas B Jacoby, Evgeny Dyskin, Murat Yalcin, Kamala Kesavan, William Dahlberg

Anticancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601).
Adam N Mamelak, Douglas B Jacoby

Expert Opin Drug Deliv· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and feasibility of percutaneous autologous skeletal myoblast transplantation in the coil-infarcted swine myocardium.
Nabil Dib, Ann Campbell, Douglas B Jacoby, Agatha Zawadzka, Judson Ratliff

J Pharmacol Toxicol Methods· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis